Prognostic role of FGFR alterations and FGFR mRNA expression in metastatic urothelial cancer treated with anti-PD(L1) inhibitors in first and second line setting

• F. Roghmann,
• R. Wirtz,
• A. Santiago-Walker,
• J. Jarczyk,
• M.C. Kriegmair,
• T.S. Worst,
• D. Sikic,
• S. Wach,
• H. Taubert,
• V. Weyerer,
• R. Stoehr,
• K. Tully,
• F. Zengerling,
• C. Bolenz,
• J. Breyer,
• M. Burger,
• S. Porubsky,
• A. Hartmann,
• P. Erben,
• M. Eckstein,
• H. Jütte

Affiliations

F. Roghmann

R. Wirtz

A. Santiago-Walker

J. Jarczyk

M.C. Kriegmair

T.S. Worst

D. Sikic

S. Wach

H. Taubert

V. Weyerer

R. Stoehr

K. Tully

F. Zengerling

C. Bolenz

J. Breyer

M. Burger

S. Porubsky

A. Hartmann

P. Erben

M. Eckstein

H. Jütte